Access cutting-edge kidney cancer treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in New Brunswick at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
The purpose of this study is to determine if the use of immunotherapy nivolumab and the targeted therapy cabozantinib prior to removal of the kidney, will increase the number subjects who are without any visible kidney cancer in their body at some point during the course of treatment.
Sponsor: Mark Stein
Check if you qualify for this kidney cancer clinical trial in New Brunswick, NJ
If you're searching for kidney cancer treatment options in New Brunswick, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.